In his first Executive Decision segment of the "Mad Money" program Wednesday,Â host Jim Cramer spoke with Kevin Sayer, chairman, president and CEO of DexCom Inc. (DXCM) , a maker of medical devices for monitoring diabetics that delivered strong earnings even with the pandemic.Sayer said DexCom has been modifying its products to interface with hospital systems so that healthcare providers can monitor the glucose levels of Covid-19 patients without entering the room.